Show simple item record

dc.contributor.authorvan Gemert, Fen
dc.contributor.authorKirenga, Ben
dc.contributor.authorChavannes, Nen
dc.contributor.authorKamya, Men
dc.contributor.authorLuzige, Sen
dc.contributor.authorMusinguzi, Pen
dc.contributor.authorTuryagaruka, Jen
dc.contributor.authorJones, Ren
dc.contributor.authorTsiligianni, Ien
dc.contributor.authorWilliams, Sen
dc.contributor.authorde Jong, Cen
dc.contributor.authorvan der Molen, Ten
dc.date.accessioned2016-01-18T11:49:43Z
dc.date.available2016-01-18T11:49:43Z
dc.date.issued2015-01en
dc.identifier.urihttp://hdl.handle.net/10026.1/4211
dc.description.abstract

BACKGROUND: In sub-Saharan Africa, little is known about the damage to respiratory health caused by biomass smoke and tobacco smoke. We assessed the prevalence of chronic obstructive pulmonary disease (COPD) and related risk factors in a rural region of Uganda. METHODS: We did this prospective observational cross-sectional study in rural Masindi, Uganda. We randomly selected people above the age of 30 years from 30 villages. Trained local health-care workers asked validated questionnaires and administered spirometry to participants. We defined COPD as FEV1:FVC less than the lower limit of normal. We calculated prevalence of COPD and tested its association with risk factors. FINDINGS: Between April 13, and Aug 14, 2012, we invited 620 people to participate, of whom 588 provided acceptable spirometry and were analysed. Mean age was 45 years (SD 13·7); 297 (51%) were women. 546 (93%) were exposed to biomass smoke. The prevalence of COPD was 16·2% (15·4% in men, 16·8% in women). Prevalence was highest in people aged 30-39 years (17 [38%] of 45 men, 20 [40%] of 50 women). 20 (44%) of 45 men with COPD were current smokers (mean age 40 years, SD 7·5), 11 (24%) were former smokers (mean age 49 years, SD 11·0); four [8%] of 50 women were current smokers (mean age 52 years, SD 18·1), nine (18%) were former smokers (mean age 64 years, SD 16·2). Mean Clinical COPD Questionnaire score was 0·81 (SD 0·78), mean Medical Research Council dyspnoea score was 1·33 (SD 0·65); 28 (30%) of 95 patients had had one or more exacerbations past 12 months. COPD was associated with wheeze (odds ratio 2·17, 95% CI 1·09-4·34; p=0·028) and being a former smoker (1·96, 1·07-3·59; p=0·029). INTERPRETATION: In this rural district of Uganda, COPD starts early in life. Major risk factors were biomass smoke for both sexes and tobacco smoke for men. In addition to high smoking prevalence in men, biomass smoke could be a major health threat to men and women in rural areas of Uganda. FUNDING: International Primary Care Respiratory Group.

en
dc.format.extente44 - e51en
dc.languageengen
dc.language.isoengen
dc.subjectAdulten
dc.subjectAgeden
dc.subjectBiomassen
dc.subjectCross-Sectional Studiesen
dc.subjectFemaleen
dc.subjectForced Expiratory Volumeen
dc.subjectHumansen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectPrevalenceen
dc.subjectProspective Studiesen
dc.subjectPulmonary Disease, Chronic Obstructiveen
dc.subjectRespiratory Soundsen
dc.subjectRisk Factorsen
dc.subjectRural Healthen
dc.subjectSmokeen
dc.subjectSmokingen
dc.subjectSpirometryen
dc.subjectSurveys and Questionnairesen
dc.subjectUgandaen
dc.subjectVital Capacityen
dc.titlePrevalence of chronic obstructive pulmonary disease and associated risk factors in Uganda (FRESH AIR Uganda): a prospective cross-sectional observational study.en
dc.typeJournal Article
plymouth.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/25539969en
plymouth.issue1en
plymouth.volume3en
plymouth.publication-statusPublisheden
plymouth.journalLancet Glob Healthen
dc.identifier.doi10.1016/S2214-109X(14)70337-7en
plymouth.organisational-group/Plymouth
plymouth.organisational-group/Plymouth/00 Groups by role
plymouth.organisational-group/Plymouth/00 Groups by role/Academics
plymouth.organisational-group/Plymouth/Faculty of Medicine and Dentistry
plymouth.organisational-group/Plymouth/Faculty of Medicine and Dentistry/Centre for Clinical Trials & Health Research
plymouth.organisational-group/Plymouth/Faculty of Medicine and Dentistry/Centre for Clinical Trials & Health Research/RC reporting group CTPS
plymouth.organisational-group/Plymouth/Faculty of Medicine and Dentistry/Collaboration for the Advancement of Medical Education Research Assessment
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA03 Allied Health Professions, Dentistry, Nursing and Pharmacy
plymouth.organisational-group/Plymouth/Research Groups
plymouth.organisational-group/Plymouth/Research Groups/Institute of Health and Community
plymouth.organisational-group/Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)
plymouth.organisational-group/Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)/CCT&PS
dc.publisher.placeEnglanden
dc.identifier.eissn2214-109Xen
dc.rights.embargoperiodNot knownen
rioxxterms.versionofrecord10.1016/S2214-109X(14)70337-7en
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserveden
rioxxterms.typeJournal Article/Reviewen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
@mire NV